Insmed (INSM) EBITDA Margin Growth (3y) (2013 - 2026)
Insmed (INSM) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | 17,708.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,708.00 |
| Dec 31, 2025 | 13,425.00 |
| Sep 30, 2025 | -6,859.00 |
| Jun 30, 2025 | -15,587.00 |
| Mar 31, 2025 | -9,817.00 |
| Dec 31, 2024 | -4,408.00 |
| Sep 30, 2024 | -684.00 |
| Jun 30, 2024 | -12,457.00 |
| Mar 31, 2024 | 1,575.00 |
| Dec 31, 2023 | 1,526.00 |
| Sep 30, 2023 | -5,793.00 |
| Jun 30, 2023 | -17,763.00 |
| Mar 31, 2023 | -6,344.00 |
| Dec 31, 2022 | -15,243.00 |
| Sep 30, 2022 | -4,327.00 |
| Jun 30, 2022 | 7,200.00 |
| Mar 31, 2022 | 14,821.00 |
| Dec 31, 2021 | 71,540.00 |
| Jun 30, 2013 | -2,293.00 |